NCT07223138 A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis Status ENROLLING_BY_INVITATION Phase PHASE3
NCT07007637 A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa Status ENROLLING_BY_INVITATION Phase PHASE3
NCT06641089 Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response Status RECRUITING Phase PHASE3
NCT06641076 Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06411899 A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Status COMPLETED Phase PHASE3
NCT06411379 Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Status COMPLETED Phase PHASE3